These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 39033421)

  • 1. Anti-inflammatory Effect of Batroxobin Combined With Anticoagulation in Patients With Cerebral Venous Thrombosis.
    Lan D; Zhang X; Huang X; Li J; Song J; Zhou D; Meng R
    Clin Appl Thromb Hemost; 2024; 30():10760296241264516. PubMed ID: 39033421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of batroxobin on the antithrombotic system in patients with cerebral venous thrombosis: Clues to mechanisms.
    Lan D; Jiao B; Song S; Wang M; Zhang X; Huang X; Guo Y; Ding Y; Ji X; Meng R
    CNS Neurosci Ther; 2024 Aug; 30(8):e14861. PubMed ID: 39097912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Batroxobin in combination with anticoagulation may promote venous sinus recanalization in cerebral venous thrombosis: A real-world experience.
    Ding JY; Pan LQ; Hu YY; Rajah GB; Zhou D; Bai CB; Ya JY; Wang ZA; Jin KX; Guan JW; Ding YC; Ji XM; Meng R
    CNS Neurosci Ther; 2019 May; 25(5):638-646. PubMed ID: 30675757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory Biomarkers Correlate with Time Evolution in Cerebral Venous Thrombosis.
    Dias L; Pinto MJ; Castro P; Carvalho M
    J Stroke Cerebrovasc Dis; 2021 Jul; 30(7):105844. PubMed ID: 33984744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Association between Inflammation and Cerebral Venous Thrombosis: A Retrospective Study.
    Zhang X; Ding R; Li H; Liu Y; Ou W; Hu J; Tian Y; Wang Q
    J Stroke Cerebrovasc Dis; 2021 Nov; 30(11):106084. PubMed ID: 34507256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of Batroxobin in combination with anticoagulation on cerebral venous sinus thrombosis.
    Ding J; Zhou D; Hu Y; Elmadhoun O; Pan L; Ya J; Geng T; Wang Z; Ding Y; Ji X; Meng R
    J Thromb Thrombolysis; 2018 Oct; 46(3):371-378. PubMed ID: 30062617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of systemic immune-inflammation index in acute deep vein thrombosis: A propensity-matched.
    Tort M; Sevil FC; Sevil H; Becit N
    J Vasc Surg Venous Lymphat Disord; 2023 Sep; 11(5):972-977.e1. PubMed ID: 37003462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Thrombo-inflammatory Biomarkers in the Prognosis of Cerebral Venous Sinus Thrombosis.
    Karahan SZ; Gazioglu S; Dilaver I; Boz C
    Curr Neurovasc Res; 2021; 18(2):237-243. PubMed ID: 34109909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multicentre clinical observation of anticoagulation and thrombolysis for the deep venous thrombosis].
    Wang HT; Jiang WL; Zhang YN; Sun ZF; Sun QF; Ma J
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(45):3181-5. PubMed ID: 20193529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can anticoagulation therapy in cerebral venous thrombosis associated with Behçet's disease be stopped without relapse?
    Roriz M; Crassard I; Lechtman S; Saadoun D; Champion K; Wechsler B; Chabriat H; Sène D
    Rev Neurol (Paris); 2018 Mar; 174(3):162-166. PubMed ID: 29523353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Risk Factors for Venous Thrombosis.
    Artoni A; Abbattista M; Bucciarelli P; Gianniello F; Scalambrino E; Pappalardo E; Peyvandi F; Martinelli I
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):808-814. PubMed ID: 29088921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study.
    Yaghi S; Shu L; Bakradze E; Salehi Omran S; Giles JA; Amar JY; Henninger N; Elnazeir M; Liberman AL; Moncrieffe K; Lu J; Sharma R; Cheng Y; Zubair AS; Simpkins AN; Li GT; Kung JC; Perez D; Heldner M; Scutelnic A; Seiffge D; Siepen B; Rothstein A; Khazaal O; Do D; Kasab SA; Rahman LA; Mistry EA; Kerrigan D; Lafever H; Nguyen TN; Klein P; Aparicio H; Frontera J; Kuohn L; Agarwal S; Stretz C; Kala N; El Jamal S; Chang A; Cutting S; Xiao H; de Havenon A; Muddasani V; Wu T; Wilson D; Nouh A; Asad SD; Qureshi A; Moore J; Khatri P; Aziz Y; Casteigne B; Khan M; Cheng Y; Mac Grory B; Weiss M; Ryan D; Vedovati MC; Paciaroni M; Siegler JE; Kamen S; Yu S; Leon Guerrero CR; Atallah E; De Marchis GM; Brehm A; Dittrich T; Psychogios M; Alvarado-Dyer R; Kass-Hout T; Prabhakaran S; Honda T; Liebeskind DS; Furie K
    Stroke; 2022 Mar; 53(3):728-738. PubMed ID: 35143325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel oral anticoagulants in the treatment of cerebral venous thrombosis.
    Feher G; Illes Z; Komoly S; Hargroves D
    Int Angiol; 2016 Aug; 35(4):365-8. PubMed ID: 25994451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Study of Cerebral Venous Sinus Thrombosis with Special Reference to Newer Risk Predictors.
    Khambholja J; Panchal SS; Gami JI
    J Assoc Physicians India; 2024 May; 72(5):45-56. PubMed ID: 38881110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do we have to anticoagulate patients with cerebral venous thrombosis?
    Feher G; Illes Z; Hargroves D; Komoly S
    Int Angiol; 2016 Aug; 35(4):369-73. PubMed ID: 26017760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting poor response to anti-coagulation therapy in cerebral venous thrombosis using a simple clinical-radiological score.
    Montalvan V; Neves G; Bueso T; Ota R; Bushnaq S; Windisch T; Bushnaq S
    J Clin Neurosci; 2022 Nov; 105():26-30. PubMed ID: 36058024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Batroxobin mobilizes circulating endothelial progenitor cells in patients with deep vein thrombosis.
    Lei Zhang ; Shi Hong Lu ; Li Li ; Tao YG; Yong Ling Wan ; Senga H; Renchi Yang ; Zhong Chao Han
    Clin Appl Thromb Hemost; 2011 Feb; 17(1):75-9. PubMed ID: 19825915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single and combined use of the platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and systemic immune-inflammation index in gastric cancer diagnosis.
    Zhang J; Zhang L; Duan S; Li Z; Li G; Yu H
    Front Oncol; 2023; 13():1143154. PubMed ID: 37064093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis: The TO-ACT Randomized Clinical Trial.
    Coutinho JM; Zuurbier SM; Bousser MG; Ji X; Canhão P; Roos YB; Crassard I; Nunes AP; Uyttenboogaart M; Chen J; Emmer BJ; Roosendaal SD; Houdart E; Reekers JA; van den Berg R; de Haan RJ; Majoie CB; Ferro JM; Stam J;
    JAMA Neurol; 2020 Aug; 77(8):966-973. PubMed ID: 32421159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral Venous Thrombosis in Hematological Malignancy: Balancing the Risks.
    Pinto MJ; Medeiros PB; Príncipe F; Carvalho M
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104683. PubMed ID: 32059925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.